Community Risk Factors for Ocular Chlamydia Infection in Niger: Pre-Treatment Results from a Cluster-Randomized Trachoma Trial

• Abdou Amza,

  Affiliation Programme National de Lutte Contre la Cecité, Niamey, Niger

  ⨯
• Boubacar Kadri,

  Affiliation Programme National de Lutte Contre la Cecité, Niamey, Niger

  ⨯
• Baido Nassirou,

  Affiliation Programme National de Lutte Contre la Cecité, Niamey, Niger

  ⨯
• Nicole E. Stoller,

  Affiliation F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Sun N. Yu,

  Affiliation F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Zhaoxia Zhou,

  Affiliation F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Stephanie Chin,

  Affiliation F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Sheila K. West,

  Affiliation Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Robin L. Bailey,

  Affiliation Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯
• David C. W. Mabey,

  Affiliation Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯
• Jeremy D. Keenan,

  Affiliations F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America, Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Travis C. Porco,

  Affiliations F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America, Institute for Global Health, University of California San Francisco, San Francisco, California, United States of America, Center for Infectious Disease and Emergency Readiness, University of California, Berkeley, California, United States of America

  ⨯
• Thomas M. Lietman,

  Affiliations F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America, Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States of America, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America, Institute for Global Health, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Bruce D. Gaynor ,

  * E-mail: bruce.gaynor@ucsf.edu

  Affiliations F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America, Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• for the PRET Partnership